You are here: Home » News-IANS » Health-Medicine
Business Standard

Novel drug to limit, repair brain damage in stroke patients

IANS  |  London 

Researchers have discovered a new drug that can potentially reduce the number of brain cells destroyed by stroke as well as help in repairing the damage done.

Stroke -- caused by a reduction in blood flow to the brain -- is a major cause of death as well as disability.

Scientists at the University of Manchester, UK, have found that in rodents with stroke, treatment with the anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra), can not only limit the death of existing brain cells but also promote the birth of new neurons.

These new cells are thought to help restore function to areas of the brain damaged by the stroke.

The use of IL-1Ra not only limits the initial damage to brain cells, but also helps the brain repair itself long-term through the generation of new brain cells, the researchers said.

Previous studies showed the treatment with IL-1Ra does indeed help rodents regain motor skills that were initially lost after a stroke. Early stage clinical trials in human stroke patients also suggest that IL-1Ra could be beneficial.

"The results lend further strong support to the use of IL-1Ra in the treatment of stroke; however, further large trials are necessary," said Stuart Allan, Professor at the University of Manchester.

The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis.

Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition, the researchers noted, in the paper published in the journal Brain, Behaviour and Immunity.

--IANS

rt/py/sac

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Novel drug to limit, repair brain damage in stroke patients

Researchers have discovered a new drug that can potentially reduce the number of brain cells destroyed by stroke as well as help in repairing the damage done.

Researchers have discovered a new drug that can potentially reduce the number of brain cells destroyed by stroke as well as help in repairing the damage done.

Stroke -- caused by a reduction in blood flow to the brain -- is a major cause of death as well as disability.

Scientists at the University of Manchester, UK, have found that in rodents with stroke, treatment with the anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra), can not only limit the death of existing brain cells but also promote the birth of new neurons.

These new cells are thought to help restore function to areas of the brain damaged by the stroke.

The use of IL-1Ra not only limits the initial damage to brain cells, but also helps the brain repair itself long-term through the generation of new brain cells, the researchers said.

Previous studies showed the treatment with IL-1Ra does indeed help rodents regain motor skills that were initially lost after a stroke. Early stage clinical trials in human stroke patients also suggest that IL-1Ra could be beneficial.

"The results lend further strong support to the use of IL-1Ra in the treatment of stroke; however, further large trials are necessary," said Stuart Allan, Professor at the University of Manchester.

The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis.

Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition, the researchers noted, in the paper published in the journal Brain, Behaviour and Immunity.

--IANS

rt/py/sac

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Novel drug to limit, repair brain damage in stroke patients

Researchers have discovered a new drug that can potentially reduce the number of brain cells destroyed by stroke as well as help in repairing the damage done.

Stroke -- caused by a reduction in blood flow to the brain -- is a major cause of death as well as disability.

Scientists at the University of Manchester, UK, have found that in rodents with stroke, treatment with the anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra), can not only limit the death of existing brain cells but also promote the birth of new neurons.

These new cells are thought to help restore function to areas of the brain damaged by the stroke.

The use of IL-1Ra not only limits the initial damage to brain cells, but also helps the brain repair itself long-term through the generation of new brain cells, the researchers said.

Previous studies showed the treatment with IL-1Ra does indeed help rodents regain motor skills that were initially lost after a stroke. Early stage clinical trials in human stroke patients also suggest that IL-1Ra could be beneficial.

"The results lend further strong support to the use of IL-1Ra in the treatment of stroke; however, further large trials are necessary," said Stuart Allan, Professor at the University of Manchester.

The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis.

Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition, the researchers noted, in the paper published in the journal Brain, Behaviour and Immunity.

--IANS

rt/py/sac

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard